Remove sun-pharma-philogen-sign-pact-to-commercialise-specialty-product-nidlegy-in-europe-australia-and-new-zealand
article thumbnail

Sun Pharma, Philogen sign pact to commercialise specialty product, NIDLEGY in Europe, Australia and New Zealand

Express Pharma

Sun Pharmaceutical Industries and Philogen have entered into a licensing agreement for commercialising Philogen’s specialty product, Nidlegy (Daromun) in the territories of Europe, Australia and New Zealand. Sun Pharma will be responsible for commercialisation activities.

72